Suppr超能文献

COPD 患者 COVID-19 疫苗接种的现状及影响因素。

The status and influencing factors of COVID-19 vaccination in patients with COPD.

机构信息

Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, 110022, China.

Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang, China.

出版信息

Sci Rep. 2024 Jul 23;14(1):16917. doi: 10.1038/s41598-024-67791-3.

Abstract

In this study, we investigated the status and influencing factors of coronavirus disease 2019 (COVID-19) vaccination in patients with chronic obstructive pulmonary disease (COPD). A questionnaire on COVID-19 vaccination in patients with COPD was developed. The clinical characteristics, COVID-19 vaccination status, other relevant vaccinations, and vaccination status of the patients with COPD were collected anonymously. Logistic regression analysis was used to analyze the factors influencing COVID-19 vaccination in patients with COPD. There were 1898 returned questionnaires, of which 1874 were valid. The proportion of patients who completed the COVID-19 vaccination program was 78.60%. Factors influencing the COVID-19 vaccination rate were: the age of individuals who were 75-85 years old and > 85 years old, acute exacerbation 3-4 times in the previous year, comorbid cardiovascular and endocrine system diseases, failure to take regular medication for COPD, application of non-invasive ventilation machines, believing that their current health condition has deteriorated, believing that the current COVID-19 vaccine is not safe, medical staff not specifying whether they would recommend vaccination against COVID-19, medical staff not recommending the COVID-19 vaccine, and fear of adverse reactions and aggravation of COPD. Patients with COPD had a high COVID-19 vaccination rate in China, whereas patients with pneumonia, influenza, and herpes zoster had a low vaccination rate. Improving the patients' understanding of the safety and effectiveness of the vaccine and promoting effective communication between medical staff and patients would help increase the vaccination rate of patients with COPD.

摘要

在这项研究中,我们调查了慢性阻塞性肺疾病(COPD)患者中 2019 年冠状病毒病(COVID-19)疫苗接种的现状和影响因素。我们开发了一份针对 COPD 患者 COVID-19 疫苗接种的问卷。匿名收集了患者的临床特征、COVID-19 疫苗接种状况、其他相关疫苗接种情况以及 COPD 患者的疫苗接种状况。使用逻辑回归分析来分析影响 COPD 患者 COVID-19 疫苗接种的因素。共收到 1898 份回复问卷,其中 1874 份有效。完成 COVID-19 疫苗接种计划的患者比例为 78.60%。影响 COVID-19 疫苗接种率的因素有:年龄在 75-85 岁和 >85 岁的个体、上一年急性加重 3-4 次、合并心血管和内分泌系统疾病、未能规律使用 COPD 药物、应用无创通气机、认为当前健康状况恶化、认为当前 COVID-19 疫苗不安全、医护人员未明确是否推荐接种 COVID-19 疫苗、医护人员不推荐 COVID-19 疫苗、担心不良反应和 COPD 加重。中国 COPD 患者 COVID-19 疫苗接种率较高,而肺炎、流感和带状疱疹疫苗接种率较低。提高患者对疫苗安全性和有效性的认识,促进医护人员与患者之间的有效沟通,有助于提高 COPD 患者的疫苗接种率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d535/11266345/b4e672139e86/41598_2024_67791_Fig1_HTML.jpg

相似文献

1
The status and influencing factors of COVID-19 vaccination in patients with COPD.
Sci Rep. 2024 Jul 23;14(1):16917. doi: 10.1038/s41598-024-67791-3.
4
Awareness of and attitude toward COVID-19 vaccination among individuals with COPD and the strategies to overcome vaccine hesitation: A mini review.
Hum Vaccin Immunother. 2023 Dec 15;19(3):2286686. doi: 10.1080/21645515.2023.2286686. Epub 2023 Dec 7.
5
The acceptance and hesitancy of COVID-19 vaccination among chronic obstructive pulmonary disease (COPD) patients.
Medicine (Baltimore). 2023 Jun 30;102(26):e33923. doi: 10.1097/MD.0000000000033923.
6
The Current Status of Vaccine Uptake and the Impact of COVID-19 on Intention to Vaccination in Patients with COPD in Beijing.
Int J Chron Obstruct Pulmon Dis. 2021 Dec 8;16:3337-3346. doi: 10.2147/COPD.S340730. eCollection 2021.
7
[Status of vaccination and related influencing factors in patients with chronic obstructive pulmonary disease: a real-world cross-sectional study].
Zhonghua Jie He He Hu Xi Za Zhi. 2022 Apr 12;45(4):355-361. doi: 10.3760/cma.j.cn112147-20211019-00727.
8
Individual preferences for COVID-19 vaccination in China.
Vaccine. 2021 Jan 8;39(2):247-254. doi: 10.1016/j.vaccine.2020.12.009. Epub 2020 Dec 5.

本文引用的文献

1
COVID-19 vaccination coverage in patients with chronic obstructive pulmonary disease - A cross-sectional study in Hungary.
Vaccine. 2023 Jan 4;41(1):193-200. doi: 10.1016/j.vaccine.2022.11.020. Epub 2022 Nov 18.
2
Assessing the COVID-19 vaccine hesitancy in the Chinese adults using a generalized vaccine hesitancy survey instrument.
Hum Vaccin Immunother. 2021 Nov 2;17(11):4005-4012. doi: 10.1080/21645515.2021.1953343.
4
GOLD report: 2022 update.
Lancet Respir Med. 2022 Feb;10(2):e20. doi: 10.1016/S2213-2600(21)00561-0. Epub 2021 Dec 20.
5
COVID-19 Vaccine Hesitancy Among Chinese Population: A Large-Scale National Study.
Front Immunol. 2021 Nov 29;12:781161. doi: 10.3389/fimmu.2021.781161. eCollection 2021.
7
The COVID-19 Vaccination Hesitancy Among the People With Inflammatory Bowel Disease in China: A Questionnaire Study.
Front Public Health. 2021 Oct 11;9:731578. doi: 10.3389/fpubh.2021.731578. eCollection 2021.
8
Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer.
JAMA Oncol. 2021 Aug 1;7(8):1242-1244. doi: 10.1001/jamaoncol.2021.1962.
10
Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study.
Lancet Respir Med. 2021 Aug;9(8):909-923. doi: 10.1016/S2213-2600(21)00095-3. Epub 2021 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验